Our technology is revolutionizing radiology. We’d love to work with you to help create better outcomes for patients everywhere.
We created the first FDA-cleared device supports concurrent reading, allowing for faster reading with proven, superior, automatic nodule detection.
Our four FDA-cleared applications are designed to improve reading efficiency and accuracy across the hospital enterprise without requiring additional hardware.
Riverain’s deep learning AI technology is FDA cleared, field tested, and clinically proven to provide real results in radiology.
Riverain Technologies advanced AI imaging software is in use by leading healthcare organizations around the world.
Peer reviews, reference accounts, and independent studies confirm that ClearRead technology is positively impacting the field of radiology.
DAYTON, Ohio – January 24, 2018 – ClearRead CT results have been published in a study titled “Computer-Aided Detection of Lung Nodules on CT with a Computerized Pulmonary Vessel Suppressed Function” in the prestigious American Journal of Roentgenology.
ClearRead CT is comprised of two powerful tools, ClearRead CT | Vessel Suppress and ClearRead CT | Detect. Deep learning enables the vessel suppression technology to assist both machine and humans in the detection and characterization of all primary nodule types, allowing for previously unattainable nodule detection performance.
The study documents the results of a multi-reader, multi-case, blinded reader study that shows the benefits of ClearRead CT both in terms of improved reading efficiency and reading accuracy.
ClearRead CT is the first FDA cleared concurrent read device incorporating a novel vessel suppression technology based on deep learning that aids in the detection and characterization of solid, part-solid and ground glass nodules.
Riverain Technologies is a leader in the commercialization of Clinical AI, offering five FDA cleared products that incorporate state-of-the-art machine learning technologies.
To learn more about Riverain Technologies and ClearRead CT, click here.